Cancer experts who advise government regulators are reviewing what could be the first gene therapy approved in the U.S.The Food and Drug Administration panel is holding a hearing Wednesday to discuss the treatment developed by the University of Pennsylvania and Novartis Corp. The drugmaker is seeking approval to use the one-time treatment for children and young adults with advanced leukemia.
NYS Entity Status
NYS Filing Date
OCTOBER 01, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - APPROVED ADVISERS AND MANAGEMENT CORP.
Around the Web
- FDA advisers review data on potential 1st US gene therapy
By LINDA A. JOHNSON, AP Medical Writer - Wednesday Jul 12, 2017
- Neighborhood Joint: Staubitz Market in Brooklyn: 100 Years of Sawdust, Steaks and Chops
By ANDREW COTTO - Wednesday Jun 14, 2017
A display contains frozen items, and the shelves are stocked with jars and cans. But there’s just one reason to visit this Boerum Hill business: meat.
- Can Gowanus Survive Its Renaissance?
By ANDY NEWMAN - Friday Oct 13, 2017
Brooklyn’s famously filthy canal is getting cleaned up. New construction is coming to the area. And not everyone is happy.
- FDA Advisers Say Yes to Experimental Cancer Therapy
By Maggie Fox - Wednesday Jul 12, 2017
FDA advisers have recommended approval of CAR-T, an experimental cancer treatment that combines genetic engineering and immunotherapy.
- Federal Jail in Brooklyn Faces a String of Sexual Assault Cases
By JOSEPH GOLDSTEIN - Tuesday Aug 1, 2017
The Metropolitan Detention Center has relatively few female inmates. Yet it accounts for a disproportionate number of sexual assault cases involving them.